Aurobindo Pharma Limited (AUROPHARMA) — Working Capital to Net Assets Ratio
Aurobindo Pharma Limited (AUROPHARMA) has a Working Capital to Net Assets ratio of 38.7% as of March 2026. Working capital of Rs146.70 Billion (current assets of Rs327.09 Billion minus current liabilities of Rs180.39 Billion) is measured against net assets of Rs378.83 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Aurobindo Pharma Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Aurobindo Pharma Limited Working Capital to Net Assets (2004–2026)
This chart shows how Aurobindo Pharma Limited's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2004 to 2026. As of March 2026, the ratio stands at 38.7%, reflecting working capital of Rs146.70 Billion against net assets of Rs378.83 Billion INR. For the complete balance sheet picture, see AUROPHARMA asset base.
Annual Working Capital to Net Assets for Aurobindo Pharma Limited (2004–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for Aurobindo Pharma Limited from 2004 to 2026, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check AUROPHARMA financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 38.7% | Rs146.70 Billion | Rs378.83 Billion | Rs327.09 Billion | Rs180.39 Billion | ▲ +0.5 pp |
| 2025 | 38.2% | Rs124.80 Billion | Rs326.47 Billion | Rs271.62 Billion | Rs146.82 Billion | ▼ -2.0 pp |
| 2024 | 40.2% | Rs120.06 Billion | Rs298.51 Billion | Rs242.06 Billion | Rs121.99 Billion | ▲ +2.8 pp |
| 2023 | 37.4% | Rs100.52 Billion | Rs268.52 Billion | Rs215.46 Billion | Rs114.94 Billion | ▼ -3.1 pp |
| 2022 | 40.6% | Rs99.67 Billion | Rs245.74 Billion | Rs181.23 Billion | Rs81.56 Billion | ▼ -1.2 pp |
| 2021 | 41.8% | Rs91.58 Billion | Rs219.29 Billion | Rs198.24 Billion | Rs106.65 Billion | ▲ +11.9 pp |
| 2020 | 29.9% | Rs50.28 Billion | Rs168.25 Billion | Rs164.13 Billion | Rs113.85 Billion | ▲ +5.8 pp |
| 2019 | 24.1% | Rs33.44 Billion | Rs138.92 Billion | Rs153.65 Billion | Rs120.21 Billion | ▼ -6.0 pp |
| 2018 | 30.1% | Rs35.12 Billion | Rs116.82 Billion | Rs121.78 Billion | Rs86.66 Billion | ▲ +2.3 pp |
| 2017 | 27.7% | Rs26.01 Billion | Rs93.74 Billion | Rs92.06 Billion | Rs66.06 Billion | ▼ -8.3 pp |
| 2016 | 36.0% | Rs24.54 Billion | Rs68.18 Billion | Rs102.94 Billion | Rs78.40 Billion | ▼ -5.7 pp |
| 2015 | 41.7% | Rs21.62 Billion | Rs51.82 Billion | Rs82.99 Billion | Rs61.36 Billion | ▲ +4.4 pp |
| 2014 | 37.4% | Rs14.11 Billion | Rs37.76 Billion | Rs56.31 Billion | Rs42.20 Billion | ▲ +10.4 pp |
| 2013 | 26.9% | Rs7.06 Billion | Rs26.22 Billion | Rs41.37 Billion | Rs34.31 Billion | ▲ +12.1 pp |
| 2012 | 14.9% | Rs3.49 Billion | Rs23.50 Billion | Rs32.64 Billion | Rs29.15 Billion | ▼ -7.7 pp |
| 2011 | 22.6% | Rs5.53 Billion | Rs24.49 Billion | Rs33.21 Billion | Rs27.68 Billion | ▼ -75.5 pp |
| 2010 | 98.1% | Rs17.98 Billion | Rs18.33 Billion | Rs25.06 Billion | Rs7.08 Billion | ▼ -40.1 pp |
| 2009 | 138.1% | Rs17.19 Billion | Rs12.44 Billion | Rs22.89 Billion | Rs5.70 Billion | ▲ +7.5 pp |
| 2008 | 130.6% | Rs14.72 Billion | Rs11.27 Billion | Rs20.59 Billion | Rs5.87 Billion | ▼ -56.5 pp |
| 2007 | 187.1% | Rs16.64 Billion | Rs8.90 Billion | Rs21.35 Billion | Rs4.71 Billion | ▲ +61.2 pp |
| 2006 | 125.9% | Rs10.29 Billion | Rs8.17 Billion | Rs14.56 Billion | Rs4.27 Billion | ▲ +28.1 pp |
| 2005 | 97.8% | Rs6.99 Billion | Rs7.14 Billion | Rs10.19 Billion | Rs3.20 Billion | ▲ +2.2 pp |
| 2004 | 95.6% | Rs6.93 Billion | Rs7.25 Billion | Rs9.59 Billion | Rs2.66 Billion | — |